Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
The author has reported on a serious problem in India. The problem of innumerable irrational fixed dose drug combinations (FDCs) being sold in Indian markets is not new. One can find any crazy drug combination which could give nightmares to any doctor who has some understanding of the concept of the rational use of medicine. It is simply beyond comprehension of any rationalist. Even antimicrobials are being combined weirdly, which is a grave challenge for crusaders against antimicrobial resistance. A list of all such FDCs which themselves need to be 'fixed' could run into pages. Only pragmatic decision backed by steely resolution can prevent such pharmaceutical misadventures to protect unsuspecting patients.
No competing interests
20 May 2015
Dr Jagjit Singh
Dr Rajiv Kumar. Professor of Pharmacology. GMCH Chandigarh.
GMCH . Chandigarh
Department of Pharmacology. Government Medical College Chandigarh. 160030 India.